Clinical efficacy and safety study of vNOTES for benign ovarian tumors in obese patients

Abstract To evaluate the clinical efficacy and safety of transvaginal natural orifice transluminal endoscopic surgery (vNOTES) for treating benign ovarian tumors in obese patients. A retrospective analysis was conducted on the clinical data of 35 obese patients who underwent vNOTES for benign ovaria...

Full description

Saved in:
Bibliographic Details
Main Authors: Fei Wang, Yuqin Liu, Yue Xing, Dongdong Wang, Xue Bai, Linlin Li, Chunhua Ma, Yongjuan Sun, Yufang Bai, Liehong Wang
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-88599-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823862325470298112
author Fei Wang
Yuqin Liu
Yue Xing
Dongdong Wang
Xue Bai
Linlin Li
Chunhua Ma
Yongjuan Sun
Yufang Bai
Liehong Wang
author_facet Fei Wang
Yuqin Liu
Yue Xing
Dongdong Wang
Xue Bai
Linlin Li
Chunhua Ma
Yongjuan Sun
Yufang Bai
Liehong Wang
author_sort Fei Wang
collection DOAJ
description Abstract To evaluate the clinical efficacy and safety of transvaginal natural orifice transluminal endoscopic surgery (vNOTES) for treating benign ovarian tumors in obese patients. A retrospective analysis was conducted on the clinical data of 35 obese patients who underwent vNOTES for benign ovarian tumor resection and 41 obese patients who underwent multi-port laparoscopic surgery (MPLS) during the same period from January 2021 to June 2024 at Qinghai Red Cross Hospital. Key parameters such as operative time, intraoperative blood loss, intraoperative and postoperative complications, hospitalization duration, postoperative anal exhaust time, postoperative visual analog scale (VAS) score, and SF-36 score were analyzed. No statistical differences were observed between the two groups regarding baseline characteristics such as age, body mass index (BMI), tumor diameter, parity, and history of pelvic surgery. The vNOTES group exhibited shorter operative times compared to the MPLS group, with no significant differences in tumor pathology, intraoperative blood loss, or tumor rupture rates. Postoperatively, the vNOTES group had shorter hospital stays, fewer postoperative complications, lower 24-hour postoperative VAS scores, and higher three-month postoperative SF-36 scores compared to the MPLS group. No differences were found between the groups concerning anal exhaust time, sexual satisfaction rate, or 24-hour postoperative VAS scores. vNOTES is a safe and feasible surgical method for treating benign ovarian tumors in obese patients, offering advantages such as no abdominal incisions and quicker postoperative recovery.
format Article
id doaj-art-a177d641dfbf401284b0413bc544b09e
institution Kabale University
issn 2045-2322
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-a177d641dfbf401284b0413bc544b09e2025-02-09T12:35:01ZengNature PortfolioScientific Reports2045-23222025-02-011511610.1038/s41598-025-88599-9Clinical efficacy and safety study of vNOTES for benign ovarian tumors in obese patientsFei Wang0Yuqin Liu1Yue Xing2Dongdong Wang3Xue Bai4Linlin Li5Chunhua Ma6Yongjuan Sun7Yufang Bai8Liehong Wang9School of Clinical Medicine, Qinghai UniversityDepartment of Gynaecology and Obstetrics, Qinghai Red Cross HospitalDepartment of Gynaecology and Obstetrics, Qinghai Red Cross HospitalSchool of Clinical Medicine, Qinghai UniversityDepartment of Gynaecology and Obstetrics, Qinghai Red Cross HospitalDepartment of Gynaecology and Obstetrics, Qinghai Red Cross HospitalDepartment of Gynaecology and Obstetrics, Qinghai Red Cross HospitalDepartment of Gynaecology and Obstetrics, Qinghai Red Cross HospitalSchool of Clinical Medicine, Qinghai UniversitySchool of Clinical Medicine, Qinghai UniversityAbstract To evaluate the clinical efficacy and safety of transvaginal natural orifice transluminal endoscopic surgery (vNOTES) for treating benign ovarian tumors in obese patients. A retrospective analysis was conducted on the clinical data of 35 obese patients who underwent vNOTES for benign ovarian tumor resection and 41 obese patients who underwent multi-port laparoscopic surgery (MPLS) during the same period from January 2021 to June 2024 at Qinghai Red Cross Hospital. Key parameters such as operative time, intraoperative blood loss, intraoperative and postoperative complications, hospitalization duration, postoperative anal exhaust time, postoperative visual analog scale (VAS) score, and SF-36 score were analyzed. No statistical differences were observed between the two groups regarding baseline characteristics such as age, body mass index (BMI), tumor diameter, parity, and history of pelvic surgery. The vNOTES group exhibited shorter operative times compared to the MPLS group, with no significant differences in tumor pathology, intraoperative blood loss, or tumor rupture rates. Postoperatively, the vNOTES group had shorter hospital stays, fewer postoperative complications, lower 24-hour postoperative VAS scores, and higher three-month postoperative SF-36 scores compared to the MPLS group. No differences were found between the groups concerning anal exhaust time, sexual satisfaction rate, or 24-hour postoperative VAS scores. vNOTES is a safe and feasible surgical method for treating benign ovarian tumors in obese patients, offering advantages such as no abdominal incisions and quicker postoperative recovery.https://doi.org/10.1038/s41598-025-88599-9vNOTESObesityBenign ovarian tumorClinical efficacyRetrospective analysis
spellingShingle Fei Wang
Yuqin Liu
Yue Xing
Dongdong Wang
Xue Bai
Linlin Li
Chunhua Ma
Yongjuan Sun
Yufang Bai
Liehong Wang
Clinical efficacy and safety study of vNOTES for benign ovarian tumors in obese patients
Scientific Reports
vNOTES
Obesity
Benign ovarian tumor
Clinical efficacy
Retrospective analysis
title Clinical efficacy and safety study of vNOTES for benign ovarian tumors in obese patients
title_full Clinical efficacy and safety study of vNOTES for benign ovarian tumors in obese patients
title_fullStr Clinical efficacy and safety study of vNOTES for benign ovarian tumors in obese patients
title_full_unstemmed Clinical efficacy and safety study of vNOTES for benign ovarian tumors in obese patients
title_short Clinical efficacy and safety study of vNOTES for benign ovarian tumors in obese patients
title_sort clinical efficacy and safety study of vnotes for benign ovarian tumors in obese patients
topic vNOTES
Obesity
Benign ovarian tumor
Clinical efficacy
Retrospective analysis
url https://doi.org/10.1038/s41598-025-88599-9
work_keys_str_mv AT feiwang clinicalefficacyandsafetystudyofvnotesforbenignovariantumorsinobesepatients
AT yuqinliu clinicalefficacyandsafetystudyofvnotesforbenignovariantumorsinobesepatients
AT yuexing clinicalefficacyandsafetystudyofvnotesforbenignovariantumorsinobesepatients
AT dongdongwang clinicalefficacyandsafetystudyofvnotesforbenignovariantumorsinobesepatients
AT xuebai clinicalefficacyandsafetystudyofvnotesforbenignovariantumorsinobesepatients
AT linlinli clinicalefficacyandsafetystudyofvnotesforbenignovariantumorsinobesepatients
AT chunhuama clinicalefficacyandsafetystudyofvnotesforbenignovariantumorsinobesepatients
AT yongjuansun clinicalefficacyandsafetystudyofvnotesforbenignovariantumorsinobesepatients
AT yufangbai clinicalefficacyandsafetystudyofvnotesforbenignovariantumorsinobesepatients
AT liehongwang clinicalefficacyandsafetystudyofvnotesforbenignovariantumorsinobesepatients